Street Calls of the Week
PLANO, Texas - Integer Holdings Corporation (NYSE:ITGR), a medical device contract development and manufacturing organization with a market capitalization of $2.59 billion and "GREAT" financial health according to InvestingPro, announced Friday that Payman Khales has assumed the role of President and Chief Executive Officer, completing a planned leadership transition that was first announced in April 2025.
Khales succeeds Joseph Dziedzic, who is retiring after eight years as Integer’s President and CEO. Under Dziedzic’s leadership, the company achieved notable growth, with revenue increasing by 9.64% over the last twelve months. Dziedzic will continue to serve as an advisor through March 31, 2026, to support the transition. Khales has also joined the company’s Board of Directors.
"I am energized by the opportunities ahead as we continue to advance our strategy," said Khales. "Together with our talented associates, we will create value by innovating, collaborating with our customers, and delivering life-changing medical technologies to patients around the world."
Khales joined Integer in 2018 as President of the Cardio & Vascular business, where he led a strategy that doubled sales in seven years. Most recently, he served as Chief Operating Officer, overseeing both of Integer’s business units and its global operations.
Prior to joining Integer, Khales held senior leadership roles at CECO Environmental Corp. and Ingersoll Rand Company. He holds an Executive MBA from Indiana University’s Kelley School of Business and a Bachelor of Science in Mechanical Engineering from École Polytechnique de Montréal.
Integer Holdings Corporation describes itself as one of the largest medical device contract development and manufacturing organizations globally, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. According to InvestingPro analysis, the company appears undervalued based on its Fair Value calculation, with strong liquidity indicated by a current ratio of 3.41. Analysts maintain a strong buy consensus on the stock, and subscribers can access the comprehensive Pro Research Report for deeper insights into Integer’s market position and growth potential.
The information in this article is based on a press release issued by Integer Holdings Corporation.
In other recent news, Integer Holdings Corporation reported its third-quarter 2025 earnings, surpassing market expectations. The company achieved an adjusted EPS of $1.79, exceeding the forecast of $1.68, and reported revenue of $468 million, slightly above the anticipated $466.45 million. Despite these positive earnings results, the company is facing challenges, as reflected by downgrades from major financial institutions. BofA Securities downgraded Integer Holdings from Buy to Neutral, citing concerns over the company’s growth prospects and high customer concentration, with the top three customers accounting for about 50% of revenue. The price target was significantly reduced to $87.00 from $135.00. Similarly, Wells Fargo downgraded the stock from Overweight to Equal Weight, setting a new price target of $80.00, down from $132.00. This downgrade was influenced by Integer’s revised 2026 outlook, which included lowered demand forecasts for key products. These developments indicate a cautious sentiment among analysts regarding Integer Holdings’ future performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.